LAURIE GARNER: Open Payments
NPI 1598766701 · VERSAILLES, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,322 in 34 payments from 14 companies in 2025. Trend: 2023 $7,074 · 2024 $6,180 · 2025 $6,322
Consulting: $5,544Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 2 | $5,544 |
| Novo Nordisk Inc | 15 | $422 |
| Mallinckrodt Hospital Products Inc. | 1 | $102 |
| PFIZER INC. | 4 | $63 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| KYOWA KIRIN, INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: KISUNLA, TERLIVAZ, Ozempic, Wegovy, PREVNAR 20, ELIQUIS, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
